Facebook
Twitter
LinkedIn
ForwardNeurocognitive Therapies and Translational Research Webinar Series: Neuroethics for the Neurosciences
Neuroethical thinking has been increasingly incorporated into neuroscience discovery, translation, and commercialization over the past 20 years. We will discuss how this growth has occurred using case examples from neuroimaging and other modalities. We will also look to the future where interdisciplinary and intersectional alignment of the life sciences and humanities on the diverse world landscape will become even more important than ever before.
June 15, 2021 at 9:00AM PST/12:00AM EST (other time zones)
Dr. Illes is Professor of Neurology and Canada Research Chair in Neuroethics at UBC. She is Director of Neuroethics Canada, and faculty in the Centre for Brain Health and at the Vancouver Coastal Health Research Institute. She received her PhD in Hearing and Speech Sciences, and in Neuropsychology at Stanford University, and became one of the pioneers of the field of neuroethics formally established in early 2000. Dr. Illes’ research, teaching and outreach initiatives are devoted to ethical, legal, social and policy challenges at the intersection of the brain sciences and biomedical ethics. She has made groundbreaking contributions to neuroethical thinking for neuroscience discovery and clinical translation specifically in the areas of neuroimaging, and neuromodulation across the lifespan, more broadly to entrepreneurship and the commercialization of health care. Dr. Illes is co-Lead of the Canadian Brain Research Strategy. She was elected to the Royal Society of Canada in 2012 and appointed to the Order of Canada in December 2017, the highest award for citizens in her country.
Target Audience
This program was designed for physicians, nurses, nurse practitioners, psychologists, and social workers.
Learning Objectives
Neurocognitive Therapies and Translational Research Webinar Series:
- To evaluate promising neuroscientific findings in the areas of emotion, socioemotional learning and development, cognition, and therapeutic change that have significant potential to improve prevention and intervention efforts for mental illness.
- To recognize common barriers to the translation and adoption of basic science in real-world clinical practice.
Upon completion of this activity, participants should be able to:
- Demonstrate familiarity with neuroethics and health ethics frameworks.
- Practice alignment of ethics lens to neuroimaging research and clinical translation.
- Assess special considerations for vulnerable and historically marginalized populations.
- Explain the global initiatives
Live Zoom link: https://washington.zoom.us/j/95151410289
Presenter: Judy Illes, C.M., Ph.D.
Dr. Illes is Professor of Neurology and Canada Research Chair in Neuroethics at UBC. She is Director of Neuroethics Canada, and faculty in the Centre for Brain Health and at the Vancouver Coastal Health Research Institute. She received her PhD in Hearing and Speech Sciences, and in Neuropsychology at Stanford University, and became one of the pioneers of the field of neuroethics formally established in early 2000. Dr. Illes’ research, teaching and outreach initiatives are devoted to ethical, legal, social and policy challenges at the intersection of the brain sciences and biomedical ethics. She has made groundbreaking contributions to neuroethical thinking for neuroscience discovery and clinical translation specifically in the areas of neuroimaging, and neuromodulation across the lifespan, more broadly to entrepreneurship and the commercialization of health care. Dr. Illes is co-Lead of the Canadian Brain Research Strategy. She was elected to the Royal Society of Canada in 2012 and appointed to the Order of Canada in December 2017, the highest award for citizens in her country.
Planning Commitee:
Judy Callan, PhD RN
Rudi De Raedt, PhD
Angela Fang, PhD
Ryan Jane Jacoby, Ph.D.
Maria Kryza-Lacombe, PhD
Andrew Peckham, PhD
Greg Siegle, PhD
Marlene Strege,PhD
Michael Thase, MD
Conflict of Interest Disclosure:
Dr. Jacoby receives grant/research support from the National Institute of Mental Health under award number K23 MH120351. In the last year she has also received salary and research support from the International OCD Foundation, the Charles A. King Trust Postdoctoral Research Fellowship Program (Bank of America, N.A., Co-Trustees), the Harvard University Mind Brain Behavior Initiative, the Harvard University Department of Psychiatry Livingston Fellowship Award, and the Harvard University Pershing Square Fund for Research on the Foundations of Human Behavior. Dr. Jacoby has received salary support from Telefonica Alpha, Inc. She is paid as a faculty member of the Massachusetts General Hospital Psychiatry Academy. She also receives book royalties from Hogrefe Publishing.
Dr. Peckham receives research support from NIH, McLean Hospital and Harvard Medical School.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Disclaimer Statement
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 1.00 Attendance